Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 6, 2009, Pages 1253-1259

  Reni, Michele ^a   Cereda, S ^a   Balzano, G ^a   Passoni, P ^a   Rognone, A ^a   Zerbi, A ^a   Nicoletti, R ^a   Mazza, E ^a   Arcidiacono, P G ^a   Di Carlo, V ^a   Villa, E ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Chemotherapy; Locally advanced pancreatic cancer; Pancreatic cancer; Radiotherapy; Stage III pancreatic cancer

Indexed keywords

CAPECITABINE; CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; GEMCITABINE; HEMOGLOBIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; DIARRHEA; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; FATIGUE; FEASIBILITY STUDY; FEMALE; HAND FOOT SYNDROME; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SIDE EFFECT; STOMATITIS; THROMBOCYTE; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; VOMITING;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DRUG THERAPY, COMBINATION; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 69049094889     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-0995-8     Document Type: Article

References (28)

1. JP Neoptolemos DD Stocken H Friess, et al. 2004 A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 1200 1210
2. H Oettle S Post P Neuhaus, et al. 2007 Adjuvant chemotherapy with Gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer. A randomized controlled trial JAMA 297 267 277
3. Sobin LH, Wittekind CH (eds) (2002) Exocrine pancreas. In: AJCC cancer staging manual, 6th edn. Springer, New York, p 157
4. C Moertel D Childs R Reitmeier MY Colby Jr MA Holbrook 1969 Combined 5FU and supervoltage RT for locally unresectable GI cancer Lancet 2 865 867
5. CG Moertel S Frytak RG Hahn, et al. 1981 Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group Cancer 48 1705 1710
6. DJ Klaassen JM MacIntyre GE Catton, et al. 1985 Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil-An Eastern Cooperative Oncology Group study J Clin Oncol 3 373 378
7. Gastrointestinal Tumor Study Group 1988 Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone J Natl Cancer Inst 80 751 755
8. Loehrer PJ Sr, Powell ME, Cardenes HR, Wagner L, Brell M, Ramanathan RK, Crane CH, Alberts SR, Benson III AB (2008) A randomised phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer:E4201. Proc Am Soc Clin Oncol 26, OP 4506
9. Chauffert B, Mornex F, Bonnetain F et al (2008) Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. Ann Oncol 19(9):1592-1599
10. A Sultana C Tudur Smith D Cunningham N Starling D Tait JP Neoptolemos P Ghaneh 2007 Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy Br J Cancer 96 8 1183 1190
11. F Huguet T André P Hammel, et al. 2007 Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR Phase II and III Studies J Clin Oncol 20 326 331
12. M Reni P Passoni MG Panucci R Nicoletti L Galli G Balzano A Zerbi V Di Carlo E Villa 2001 Definitive results of a phase ii trial of PEF-G (cisplatin, epirubicin, 5-fluorouracil continuous infusion, gemcitabine) in stage IV pancreatic adenocarcinoma J Clin Oncol 19 2679 2686
13. M Reni S Cordio C Milandri P Passoni E Bonetto C Oliani G Luppi R Nicoletti L Galli R Bordonaro A Passardi A Zerbi G Balzano L Aldrighetti C Staudacher E Villa V Di Carlo 2005 Gemcitabine versus cisplatin, epirubicin, 5-fluorouracil, gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial Lancet Oncol 6 369 376
14. M Reni S Cereda E Bonetto, et al. 2007 Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding study Cancer Invest 25 594 598
15. M Reni S Cereda E Bonetto MG Viganò P Passoni A Zerbi G Balzano R Nicoletti C Staudacher V Di Carlo 2007 Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma Cancer Chemother Pharmacol 59 361 367
16. Reni M, Cereda S, Passoni P, Rognone A, Mazza E, Nicoletti R, Arcidiacono P, Zerbi A, Balzano G, Di Carlo V (2007) A randomized phase II trial of PEXG (cisplatin, epirubicin, capecitabine, gemcitabine) or PDXG (docetaxel) regimen in advanced pancreatic adenocarcinoma. Proc Am Soc Clin Oncol 25 (abstract 4628)
17. Therasse P, Arbuck SG, Eisenhaur EA, Wanders J, Kaplan RS, Rubinstein L et al (2004) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205-216
18. JA Ajani SR Welch MN Raber WS Fields IH Krakoff 1990 Comprehensive criteria for assessing therapy-induced toxicity Cancer Invest 8 147 159
19. Reni M, Cereda S, Balzano G, Passoni P, Rognone A, Ceraulo D, Fugazza C, Mazza E, Zerbi A, Di Carlo V, Villa E (2009) Carbohydrate antigen (CA)19-9 change during chemotherapy for advanced pancreatic adenocarcinoma. Cancer (in press)
20. MG Haddock R Swaminathan NR Foster MD Hauge JA Martenson JK Camoriano PJ Stella RC Tenglin PL Schaefer DF Moore Jr SR Alberts 2007 Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942 J Clin Oncol 25 18 2567 2572
21. AH Ko JM Quivey AP Venook EK Bergsland E Dito B Schillinger MA Tempero 2007 A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 68 3 809 816
22. A Brade J Brierley A Oza S Gallinger B Cummings M Maclean GR Pond D Hedley S Wong C Townsley C Brezden-Masley M Moore 2007 Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study Int J Radiat Oncol Biol Phys 67 4 1027 1036
23. A Magnino M Gatti P Massucco E Sperti R Faggiuolo D Regge L Capussotti P Gabriele M Aglietta 2005 Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer Oncology 68 4-6 493 499
24. CH Crane LM Ellis JL Abbruzzese C Amos HQ Xiong L Ho DB Evans EP Tamm C Ng PWT Pisters C Charnsangavej ME Delclos M O'Reilly JE Lee RA Wolff 2006 Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer J Clin Oncol 24 1145 1151
25. JL Marti HS Hochster SP Hiotis B Donahue T Ryan E Newman 2008 Phase I/II trial of induction chemotherapy followed by concurrent chemoradiotherapy and surgery for locoregionally advanced pancreatic cancer Ann Oncol 15 12 3521 3531
26. L Moureau-Zabotto J-M Phelip P Afchain L Mineur T André V Vendrely G Lledo O Dupuis F Huguet E Touboul J Balosso C Louvet 2008 Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinaire en Oncologie phase II study J Clin Oncol 26 1080 1085
27. G Balzano A Zerbi G Capretti S Rocchetti V Capitanio V Di Carlo 2008 Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy Br J Surg 95 357 362
28. TA Sohn KD Lillemoe JL Cameron, et al. 1999 Reexploration for periampullary carcinoma: resectability, perioperative results, pathology, and long-term outcome Ann Surg 229 393 400